Cardiac Marker Testing Market Overview, Growth, Trends, Analysis (2021-2031)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Cardiac Marker Testing Market covers analysis By Product Type (Reagents and Kits, Instruments); Biomarker Type (Troponin I and T, CK-MB, BNP, Myoglobin, Hs-CRP, Other Biomarkers); Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Ischemia); End User (Laboratory Testing, Point-Of-Care-Testing, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00022451
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Jan 2025

AI overview of Cardiac Marker Testing Market


The Cardiac Marker Testing Market is poised for significant growth, projected to reach a market size of US$ XX million by 2031, with a robust CAGR of 9.1% from 2025 to 2031. This growth is driven by the rising prevalence of cardiovascular diseases and advancements in diagnostic technologies. Key segments include various biomarker types such as Troponin and CK-MB, and applications ranging from myocardial infarction to acute coronary syndrome. The market is also witnessing a shift towards point-of-care testing, integrating artificial intelligence and data analytics to enhance diagnostic accuracy. As awareness of preventive healthcare increases, the Cardiac Marker Testing Market is expected to expand, particularly in emerging markets, presenting new opportunities for innovation and personalized medicine.


The Cardiac Marker Testing Market is expected to register a CAGR of 9.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented By Product Type (Reagents and Kits, Instruments); Biomarker Type (Troponin I and T, CK-MB, BNP, Myoglobin, Hs-CRP, Other Biomarkers); Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Ischemia); End User (Laboratory Testing, Point-Of-Care-Testing, Others). The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Cardiac Marker Testing Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Cardiac Marker Testing Market Segmentation

Product Type

  • Reagents and Kits
  • Instruments

Biomarker Type

  • Troponin I and T
  • CK-MB
  • BNP
  • Myoglobin
  • Hs-CRP
  • Other Biomarkers

Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Ischemia

End User

  • Laboratory Testing
  • Point-Of-Care-Testing
  • Others

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Cardiac Marker Testing Market: Strategic Insights

cardiac-marker-testing-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Cardiac Marker Testing Market Growth Drivers

  • Rising Prevalence of Cardiovascular Diseases: Another major reason fuelling the expansion of the cardiac marker testing market is the increasing prevalence of cardiovascular diseases (CVD) around the globe. With heart attacks, strokes, and heart failures becoming more common there is also a rising need for advanced effective diagnostic means in establishing the critical primary preconditions of all heart diseases. The rise in demand for cardiac markers has contributed to the growth of the market since these tests are significant in commencement and conclusion of treatment.
  • Advancements in Diagnostic Technologies: Newer Technologies Focused on Diagnostic Purposes are improving the performance of cardiac markers. Point of care, rapid testing kits, better biomarkers are among other newer technologies enabling faster and easier testing. Such technological advancements which entail quicker and accurate results are enhancing the use of cardiac marker tests hence extending the market.
  • Growing Awareness and Preventive Healthcare: This is due to the fact that more people are now aware of the dangers of heart diseases and the importance of preventing them which helps in the expansion of the market for cardiac marker testing. As more patients begin concentrating on preventative healthcare and on the control of risk factors of cardiovascular disease, the supply of early diagnostic examination grows. As people prefer health management above treatment, such tendency leads to an increased market demand for effective cardiac marker figurative examinations.

Cardiac Marker Testing Market Future Trends

  • Shift Toward Point-of-Care Testing: One of the most pronounced trends in the cardiac marker testing market is the increase in shift towards point of care (POC) testing. The POC device facilitates test results on site in a much easier fashion making it possible to get results in time in case of emergency settings and even in related outpatient clinics. This trend is beneficial in increasing the efficiency of cardiac care by allowing quick diagnostics hence minimizing on the time wasted in hospital queues thus improving the clinical outcomes of patients and as a result expanding the market.
  • Integration of Artificial Intelligence and Data Analytics: Artificial intelligence (AI) and data analytics have improved the cardiac marker testing market. Test results can be interpreted with a higher degree of accuracy with the use of AI algorithms such that risks for heart diseases can also be predicted. Such advances are most often seen in diagnostic devices based on x-ray or magnetic resonance imaging, facilitating their healthy development, creating and satisfying a need for developments in the cardiac testing market.
  • Emergence of Biomarker-Based Panels: There is an emerging trend in the cardiac testing market where panels of multi-biomarker are being developed. Such panels include the use of several biomarkers to help define a specific heart disease more precisely enhancing its diagnosis as well as risk assessment. Such biomarker panels as are more predictive in nature help in early diagnosis and management of cardiovascular diseases which is why there is increasing use of such panels in clinical practice thus there is an increase in the market growth.

Cardiac Marker Testing Market Opportunities

  • Expansion in Emerging Markets: The healthcare system in these emerging markets is, however, significantly developed especially that which has led to the establishment of a market for cardiac biomarker testing services. In view of this, it can be noted that Asia-pacific and Latin America suffer a larger population who are at risk of cardiac ailments as well as having high-end diagnostic equipment. In those markets, the expansion of diagnostic marker testing technologies for cardiac markers is envisaged which will also aid in diagnosis and prevention of cardiovascular diseases.
  • Integration with Telemedicine and Remote Monitoring: The expansion of telehealth services and virtual consultations has advanced the process and the procedure of assessing cardiac markers, especially in the mobile or off-site settings. Bearing in mind the still quite recent upward developmental trend in telemedicine, from which one encounters numerous challenges especially in the remote latitudes, one can comfortably envisage that an area such as cardiology will be within the reach of patients who reside at the farthest latitudes. All this transform's people's attitudes towards using advanced diagnostic tests for heart diseases and most significantly, how the Center for this vital diagnostic services is made available to as many patients as possible.
  • Development of Personalized Medicine: With the present advancements in the healthcare whereby personalized medicine is on the fore front, the opportunities for cardiac markers testing are increasing as well. It is effective to prevent and treat cardiovascular diseases according to the individual biomarker signatures. This is the reason why the advanced multi markers tests are in high demand, which creates hopes for the future of the market in terms of further expansion and innovations.

Cardiac Marker Testing Market Regional Insights

The regional trends and factors influencing the Cardiac Marker Testing Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Cardiac Marker Testing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Cardiac Marker Testing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 9.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • Reagents and Kits
  • Instruments
By Biomarker Type
  • Troponin I and T
  • CK-MB
  • BNP
  • Myoglobin
  • Hs-CRP
  • Other Biomarkers
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Ischemia
By End User
  • Laboratory Testing
  • Point-Of-Care-Testing
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Roche Diagnostics Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Ortho Clinical Diagnostics
  • Randox laboratories Ltd.
  • bioMérieux SA
  • LSI Medience Corporation
  • DiaSorin S.p.A.

  • Cardiac Marker Testing Market Players Density: Understanding Its Impact on Business Dynamics

    The Cardiac Marker Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    cardiac-marker-testing-market-cagr

    • Get the Cardiac Marker Testing Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cardiac Marker Testing Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Cardiac Marker Testing Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What is the expected CAGR of the Cardiac Marker Testing Market?
    The Cardiac Marker Testing Market is estimated to witness a CAGR of 9.1% from 2023 to 2031
    2
    What are the driving factors impacting the cardiac marker testing market?
    The major factors driving the cardiac marker testing market are:

    1.Rising Prevalence of Cardiovascular Diseases

    2. Advancements in Diagnostic Technologies

    3. Growing Awareness and Preventive Healthcare
    3
    Which region dominated the cardiac marker testing market in 2023?
    North America region dominated the cardiac marker testing market in 2023
    4
    Which region highest CAGR the cardiac marker testing market in 2023?
    Asia Pacific region dominated the cardiac marker testing market in 2023
    5
    Which segment accounts for highest revenue in product type segment of the cardiac marker testing market in 2023?
    The Instruments segment accounts for highest revenue in animal type sgement in 2023
    6
    Which are some of the major players operating in the market?
    Roche Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Ortho Clinical Diagnostics, Randox laboratories Ltd., bioMérieux SA, LSI Medience Corporation, DiaSorin S.p.A., Bio-Rad Laboratories, Inc. are some of the major market players operating in the market
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Roche Diagnostics Ltd
    2. Abbott Laboratories
    3. Siemens Healthineers AG
    4. Danaher Corporation
    5. Ortho Clinical Diagnostics
    6. Randox laboratories Ltd.
    7. bioMérieux SA
    8. LSI Medience Corporation
    9. DiaSorin S.p.A.
    10. Bio-Rad Laboratories, Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo